Managing Director K Anand Kumar in a release on Friday said the firm is expected to produce the drug substance initially for 2-3 million doses per month.from News-Economic Times https://ift.tt/3yMo1jK
Indian Immunologiclas to start drug substance production for Covaxin from June
Managing Director K Anand Kumar in a release on Friday said the firm is expected to produce the drug substance initially for 2-3 million doses per month.from News-Economic Times https://ift.tt/3yMo1jK
Related Posts:
View: Free coronavirus vaccinations are better than any stimulus the Centre can provide- View: The Supreme Court should stay off legislative, executive turf on the Farm Bills
- Vaxman Rekha: Some wary of going to the other side
- Maldives' first foreign funded project of 2021 backed by India inaugurated
- Trump brand tarnished after bruising presidency and Capitol attack
0 Comments:
Post a Comment